The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

por Young, K. E., Soussi, I., Toumi, M.
Publicado 2017

Healthcare resource use in schizophrenia, EuroSC findings

por Millier, A., Horváth, M., Ma, F., Kóczián, K., Götze, A., Toumi, M.
Publicado 2017

EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England

por Aballea, S, Karwala, P, Zerda, I, Toumi, M, Pochopien, M, Borissov, B, Clay, E
Publicado 2022

Annealing effect on the physical properties of TiO(2) thin films deposited by spray pyrolysis

por Alaya, Y., Souissi, R., Toumi, M., Madani, M., El Mir, L., Bouguila, N., Alaya, S.
Publicado 2023

Filling the gap in CNS drug development: evaluation of the role of drug repurposing

por Caban, A., Pisarczyk, K., Kopacz, K., Kapuśniak, A., Toumi, M., Rémuzat, C., Kornfeld, A.
Publicado 2017

P2 The Value of Vaccination: Capturing the Impact of Vaccination on Health Equity in Health Economic Analysis

por Dronova, M., Biundo, E., Chicoye, A., Cookson, R., Devlin, N., Doherty, M., Garcia, S., Garcia-Ruiz, A.J., Garrison, L., Toumi, M., Nolan, T., Postma, M.J., Salisbury, D., Wasem, J., Beck, E.
Publicado 2022